Skip to main content

The Scientist Speaks Ep. 13 - The Long Haul: Improving Cardiac Cell Therapy Persistence

Researchers remuscularize the heart after cardiac infarction with stem cell-derived cardiomyocytes and ready-made microvessels.

Written byNiki Spahich, PhD
| 1 min read
Improving Cardiac Cell Therapy Persistence

Register for free to listen to this article
Listen with Speechify
0:00
1:00

Cell therapies treat and repair the body using stem cells or their derivatives. These cells possess great therapeutic potential, but their beneficial effects often fade away over time. In this episode, we explore strategies to improve the persistence of stem cell-derived cardiomyocytes in the effort to remuscularize hearts after cardiac infarction.

Niki Spahich from The Scientist’s Creative Services team spoke with Sara Nunes Vasconcelos, an assistant professor at the Institute of Biomaterials & Biomedical Engineering, University of Toronto, and a scientist at the Toronto General Hospital Research Institute, to learn more.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Niki Spahich headshot

    Niki Spahich earned her PhD in genetics and genomics from Duke University, where she studied Haemophilus influenzae membrane proteins that contribute to respiratory infections. She later explored Staphylococcus aureus metabolism during her postdoctoral fellowship in the Department of Microbiology and Immunology at the University of North Carolina at Chapel Hill. Prior to joining The Scientist, Niki taught biology, microbiology, and genetics at various academic institutions. She also developed a passion for science communication in written, visual, and spoken forms, which led her to start Science Riot, a nonprofit dedicated to teaching scientists how to communicate to the public through the lens of comedy. Niki is currently the manager of The Scientist's Creative Services Team.

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays